Donepezil Hydrochloride/Mefloquine Hydrochloride

盐酸多奈哌齐/盐酸甲氟喹

Report date: 2024/12/25 20:00:50

Base Information

Drug NameDonepezil Hydrochloride/Mefloquine Hydrochloride
Drug Alias NameMefloquine/Donepezil盐酸多奈哌齐+盐酸甲氟喹Donepezil+Mefloquine盐酸甲氟喹/盐酸多奈哌齐Mefloquine+Donepezil +[8
ClassificationSmall molecules
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsCognition DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheranexus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheranexus
Active IndicationsN/A
Inactive IndicationsCognition DisordersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A